Mesoblast stem cell therapy approved by Japanese health watchdog

Mesoblast has won full regulatory approval for its first stem cell therapy from the Japanese health regulator, paving the way for the biotechnology company to receive royalties to fund expensive clinical trials. On Friday the Japanese Ministry of Health …

[Read the full article here]

Comments are closed.